Shares of Power Grid Corporation of India dropped 3.6% after reporting a 4% decline in consolidated net profit for the ...

Power Grid Q3 Results: The PSU’s net profit dropped four per cent to ₹3,861.6 crore dragged by weak demand in the third ...

Power Grid Corporation of India reported a 4% drop in its consolidated net profit for the December 2024 quarter, totaling Rs ...

The research offers hope to tens of thousands of patients with kidney failure who are on a long waiting list for an organ transplant. By Roni Caryn Rabin The U.S. Food and Drug Administration has ...

Power Grid Corporation of India's net profit fell 4% to Rs 3,861.63 crore in the December 2024 quarter, with total income ...

The new biosimilar, Celltrion’s Avtozma, was approved in both IV and subcutaneous forms to treat inflammatory conditions such as arthritis. The FDA has approved Celltrion’s similar of Genentech’s ...

The US Food and Drug Administration (FDA) has approved Avtozma (tocilizumab-anoh) as a biosimilar of the original reference biologic tocilizumab (Actemra), according to a January 30 announcement ...

Disney posted a 35% increase in earnings per share and 5% increase in total revenue in its first quarter of 2025, boosted by ...

Power Grid Corporation of India reported a 4% year-on-year decline in net profit for the December 2024 quarter to Rs 3,861.63 ...

Copyright 2025 The Associated Press. All Rights Reserved. President Donald Trump and first lady Melania Trump listen to California Gov. Gavin Newsom after arriving on ...

WASHINGTON, Feb 4 (Reuters) - The U.S. State Department has approved the potential sale of Lockheed Martin (LMT.N), opens new tab and Northrop Grumman Corp's (NOC.N), opens new tab defense systems ...

Onapgo, a subcutaneous apomorphine infusion device, is approved for advanced Parkinson's disease, offering continuous symptom management without surgery. The TOLEDO trial showed apomorphine ...